Locations
Cambridge, MA, USA · Waltham, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Lucy Therapeutics is a biotech company focused on developing innovative treatments for neurological diseases by targeting mitochondrial dysfunction. The company differentiates itself through a unique approach to drug discovery that addresses early disease pathogenesis, particularly in conditions like Parkinson's and Alzheimer's diseases. With a strong emphasis on research and development, Lucy Therapeutics aims to build a robust pipeline of therapeutic agents, leveraging significant funding and grants to advance its medical research programs. The company is positioned to make a substantial impact in the biotech industry, particularly in the realm of CNS diseases, by providing novel solutions that address critical unmet medical needs.
Something looks off?